Search Results 1011-1020 of 17909 for Assay

1. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

   Note: If the QuantiFERON-TB test is indeterminate, a second test should be performed through the central laboratory or local TB interferon gamma release assay ...

2. Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis - Mayo Clinic

   Measurable disease defined as the finding by serum-free light chain (FLC) assay that the difference between the involved and uninvolved FLC (dFLC) is ≥ 50 mg/L ...

3. Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Serum free light chain (FLC) assay; involved FLC level ≥ 10 mg/dL provided the serum FLC ratio is abnormal; OR; ≥ 30% clonal plasma cells in the bone ...

4. Nizubaglusta in Late-Infantile and Juvenile Forms of Niemann-Pick Type C Disease and GM1 Gangliosidosis or GM2 Gangliosidosis - Mayo Clinic

   ... assay on two different blood samples; Genetic test: presence of biallelic pathogenic or likely pathogenic variants according to the American College of ...

5. Obstetrics and Gynecology News - Medical Professionals - Mayo Clinic

   Challenging search for ovarian cancer early detection assay appears hopeful. In a clinical pilot study, an 11-MDM ovarian cancer panel, developed at Mayo ...

6. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

   Patients who have a positive HCV antibody test are eligible for the study if a PCR assay is negative for HCV RNA. History of other malignancies within the ...

7. A Study to Evaluate Niraparib and TSR-042 in Patients with Germline or Somatic BRCA1/2 and PALB2-related Pancreatic Cancer - Mayo Clinic

   Note: The somatic mutation could be either on a tissue-based test or the circulating tumor DNA (ctDNA)-based assay. The 6 genes that would determine ...

8. Overview - Spatial Multiomics Core - Mayo Clinic Research Core Facilities

   Human or mouse whole-transcriptome profiling is complemented with more than 570 photocleavable, oligonucleotide-tagged antibody targets that can be assayed in ...

9. Women's Health Research Center - Pilot Grants

   The team also uses a new laboratory test called seed amplification assay to detect the presence of alpha-synuclein. By identifying sex-specific patterns in ...

10. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

    Positive, indeterminate, or invalid interferon-gamma release assay test result at Screening, unless previously treated for TB. Participants with an ...